Initiator Pharma A/SOMXSTO: INIT

Initiator Pharma (Q4 Review): Dosing underway in phase IIa study

· Issued by Initiator Pharma A/S

Redeye’s analyst just published a Research Update on Initiator Pharma.

Click here to read the article

Make sure to add Initiator Pharma to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.

This is a press release from Redeye - Research Powered Investment Banking.www.redeye.se

Attachments

Initiator Pharma A/S on 6ix

Earlier from Initiator Pharma

Later from Initiator Pharma

All Initiator Pharma news releases